Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial (Q44630716)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 1, 2003
edit
Language Label Description Also known as
English
Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial
scientific article published on November 1, 2003

    Statements

    Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trial (English)
    Marilyn Mehlmauer
    Worldwide Bexarotene Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit